Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0051 | 1 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |